| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Monopar Therapeutics | Director | Common Stock | 8.76K | $597K | $68.09 | 18 Dec 2025 | Direct |
| Monopar Therapeutics | Director | Stock Options | 11.4K | 04 Mar 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MNPR | Monopar Therapeutics | 18 Dec 2025 | 2 | -$344K | 4 | Director | 19 Dec 2025, 15:43 |
| MNPR | Monopar Therapeutics | 04 Mar 2025 | 1 | $0 | 4 | Director | 07 Mar 2025, 19:58 |
| MNPR | Monopar Therapeutics | 31 Dec 2023 | 2 | $0 | 4 | Director | 03 Jan 2024, 19:38 |
| MNPR | Monopar Therapeutics | 30 Sep 2023 | 2 | $0 | 4 | Director | 03 Oct 2023, 19:34 |
| MNPR | Monopar Therapeutics | 30 Jun 2023 | 2 | $0 | 4 | Director | 03 Jul 2023, 18:49 |
| MNPR | Monopar Therapeutics | 31 Mar 2023 | 2 | $0 | 4 | Director | 04 Apr 2023, 17:20 |
| MNPR | Monopar Therapeutics | 01 Feb 2023 | 2 | $0 | 4 | Director | 03 Feb 2023, 17:47 |
| MNPR | Monopar Therapeutics | 31 Dec 2022 | 2 | $0 | 4 | Director | 03 Jan 2023, 15:09 |
| MNPR | Monopar Therapeutics | 30 Sep 2022 | 2 | $0 | 4 | Director | 03 Oct 2022, 19:45 |
| MNPR | Monopar Therapeutics | 30 Jun 2022 | 2 | $0 | 4 | Director | 01 Jul 2022, 16:19 |
| MNPR | Monopar Therapeutics | 31 Mar 2022 | 2 | $0 | 4 | Director | 01 Apr 2022, 17:03 |
| MNPR | Monopar Therapeutics | 02 Feb 2022 | 2 | $0 | 4 | Director | 04 Feb 2022, 18:30 |
| MNPR | Monopar Therapeutics | 31 Dec 2021 | 2 | $0 | 4 | Director | 04 Jan 2022, 11:59 |
| MNPR | Monopar Therapeutics | 30 Sep 2021 | 2 | $0 | 4 | Director | 01 Oct 2021, 19:26 |
| MNPR | Monopar Therapeutics | 30 Jun 2021 | 2 | $0 | 4 | Director | 02 Jul 2021, 17:16 |